✦ LIBER ✦

Low persistency with oral bisphosphonates in cancer patients

✍ Scribed by A. Hoer; H. Gothe; V. Barghout; G. Schiffhorst; B. Haeussler

Book ID: 116436575
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 48 KB
Volume: 10
Category: Article
ISSN: 1462-3889
DOI: 10.1016/j.ejon.2006.04.016

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Oral bisphosphonates are associated with

Oral bisphosphonates are associated with low persistence and compliance (adherence) in patients with breast cancer

✍ H. Gothe; Hoer; V. Barghout; G. Schiffhorst; B. Haeussler 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 138 KB

PERSISTENCE AND COMPLIANCE (ADHERENCE) W

PERSISTENCE AND COMPLIANCE (ADHERENCE) WITH ORAL BISPHOSPHONATES IN PROSTATE CANCER PATIENTS

✍ A. Hoer; H. Gothe; V. Barghout; G. Schiffhorst; B. Hauessler 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Are patients treated with oral bisphosph

Are patients treated with oral bisphosphonates at increased risk of esophageal cancer?

✍ B. Abrahamsen; P.A. Eiken; R. Eastell 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Atrial fibrillation in fracture patients

Atrial fibrillation in fracture patients treated with oral bisphosphonates

✍ B. Abrahamsen; P. Eiken; K. Brixen 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 728 KB

Fracture Outcomes Related to Persistence

Fracture Outcomes Related to Persistence and Compliance With Oral Bisphosphonates

✍ Arlene M Gallagher; Stephan Rietbrock; Melvin Olson; Tjeerd P van Staa 📂 Article 📅 2008 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 460 KB

Gastrointestinal side effects can reduce

Gastrointestinal side effects can reduce compliance with oral bisphosphonate therapy in cancer patients

✍ S. Heatley; H. Lothman; P. Major 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 37 KB